全文获取类型
收费全文 | 32343篇 |
免费 | 3333篇 |
国内免费 | 590篇 |
专业分类
耳鼻咽喉 | 157篇 |
儿科学 | 1102篇 |
妇产科学 | 592篇 |
基础医学 | 2513篇 |
口腔科学 | 341篇 |
临床医学 | 3439篇 |
内科学 | 9057篇 |
皮肤病学 | 451篇 |
神经病学 | 2176篇 |
特种医学 | 584篇 |
外科学 | 3323篇 |
综合类 | 2390篇 |
现状与发展 | 1篇 |
一般理论 | 12篇 |
预防医学 | 5923篇 |
眼科学 | 823篇 |
药学 | 1499篇 |
3篇 | |
中国医学 | 335篇 |
肿瘤学 | 1545篇 |
出版年
2024年 | 61篇 |
2023年 | 485篇 |
2022年 | 331篇 |
2021年 | 554篇 |
2020年 | 525篇 |
2019年 | 263篇 |
2018年 | 852篇 |
2017年 | 874篇 |
2016年 | 947篇 |
2015年 | 970篇 |
2014年 | 980篇 |
2013年 | 1311篇 |
2012年 | 1956篇 |
2011年 | 2909篇 |
2010年 | 1634篇 |
2009年 | 1336篇 |
2008年 | 1948篇 |
2007年 | 1889篇 |
2006年 | 1708篇 |
2005年 | 1840篇 |
2004年 | 2746篇 |
2003年 | 2448篇 |
2002年 | 1750篇 |
2001年 | 1304篇 |
2000年 | 639篇 |
1999年 | 604篇 |
1998年 | 539篇 |
1997年 | 496篇 |
1996年 | 247篇 |
1995年 | 188篇 |
1994年 | 175篇 |
1993年 | 193篇 |
1992年 | 174篇 |
1991年 | 119篇 |
1990年 | 127篇 |
1989年 | 100篇 |
1988年 | 93篇 |
1987年 | 79篇 |
1986年 | 70篇 |
1985年 | 59篇 |
1984年 | 38篇 |
1983年 | 44篇 |
1982年 | 41篇 |
1981年 | 31篇 |
1980年 | 29篇 |
1979年 | 29篇 |
1978年 | 37篇 |
1977年 | 28篇 |
1975年 | 29篇 |
1974年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Michael E Egger Joanna M Ohlendorf Charles R Scoggins Kelly M McMasters Robert C G Martin II 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2015,17(9):839-845
BackgroundThe aim of this paper is to assess the current state of quality and outcomes measures being reported for hepatic resections in the recent literature.MethodsMedline and PubMed databases were searched for English language articles published between 1 January 2002 and 30 April 2013. Two examiners reviewed each article and relevant citations for appropriateness of inclusion, which excluded papers of liver donor hepatic resections, repeat hepatectomies or meta-analyses. Data were extracted and summarized by two examiners for analysis.ResultsFifty-five studies were identified with suitable reporting to assess peri-operative mortality in hepatic resections. In only 35% (19/55) of the studies was the follow-up time explicitly stated, and in 47% (26/55) of studies peri-operative mortality was limited to in-hospital or 30 days. The time period in which complications were captured was not explicitly stated in 19 out of 28 studies. The remaining studies only captured complications within 30 days of the index operation (8/28). There was a paucity of quality literature addressing truly patient-centred outcomes.ConclusionQuality outcomes after a hepatic resection are inconsistently reported in the literature. Quality outcome studies for a hepatectomy should report mortality and morbidity at a minimum of 90 days after surgery. 相似文献
2.
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers
下载免费PDF全文
![点击此处可从《Clinical endocrinology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
3.
4.
L. Misery E. Weisshaar E. Brenaut A.W.M. Evers F. Huet S. Ständer A. Reich E. Berardesca E. Serra-Baldrich J. Wallengren D. Linder J.W. Fluhr J.C. Szepietowski H. Maibach for the Special Interest Group on sensitive skin of the International Forum for the Study of Itch 《Journal of the European Academy of Dermatology and Venereology》2020,34(2):222-229
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin – as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin. 相似文献
5.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis
下载免费PDF全文
![点击此处可从《Transfusion medicine (Oxford, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
6.
7.
8.
María Cabrerizo Gloria Trallero María José Pena Amaia Cilla Gregoria Megias Carmen Mu?oz-Almagro Eva Del Amo Diana Roda Ana Isabel Mensalvas Antonio Moreno-Docón Juan García-Costa Nuria Rabella Manuel Ome?aca María Pilar Romero Sara Sanbonmatsu-Gámez Mercedes Pérez-Ruiz María José Santos-Mu?oz Cristina Calvo And the study group of “Enterovirus parechovirus infections in children under ?years-old Spain” PI- 《European journal of pediatrics》2015,174(11):1511-1516
9.
10.
Emmi Helle Aldo Córdova-Palomera Tiina Ojala Priyanka Saha Praneetha Potiny Stefan Gustafsson Erik Ingelsson Michael Bamshad Deborah Nickerson Jessica X. Chong University of Washington Center for Mendelian Genomics Euan Ashley James R. Priest 《Genetic epidemiology》2019,43(2):215-226
Loss of function variants in NOTCH1 cause left ventricular outflow tract obstructive defects (LVOTO). However, the risk conferred by rare and noncoding variants in NOTCH1 for LVOTO remains largely uncharacterized. In a cohort of 49 families affected by hypoplastic left heart syndrome, a severe form of LVOTO, we discovered predicted loss of function NOTCH1 variants in 6% of individuals. Rare or low-frequency missense variants were found in 16% of families. To make a quantitative estimate of the genetic risk posed by variants in NOTCH1 for LVOTO, we studied associations of 400 coding and noncoding variants in NOTCH1 in 1,085 cases and 332,788 controls from the UK Biobank. Two rare intronic variants in strong linkage disequilibrium displayed significant association with risk for LVOTO amongst European-ancestry individuals. This result was replicated in an independent analysis of 210 cases and 68,762 controls of non-European and mixed ancestry. In conclusion, carrying rare predicted loss of function variants in NOTCH1 confer significant risk for LVOTO. In addition, the two intronic variants seem to be associated with an increased risk for these defects. Our approach demonstrates the utility of population-based data sets in quantifying the specific risk of individual variants for disease-related phenotypes. 相似文献